Bioxytran Inc (BIXT)
0.0996
+0.01
(+9.46%)
USD |
OTCM |
Nov 05, 15:53
Bioxytran Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2017 | 43.65% |
| June 30, 2017 | -659.8% |
| March 31, 2017 | -868.6% |
| December 31, 2016 | |
| September 30, 2016 | -211.6% |
| June 30, 2016 | -293.0% |
| March 31, 2016 | -1.44K% |
| December 31, 2015 | 5.55% |
| September 30, 2015 | -27.18% |
| June 30, 2015 | -3.23K% |
| March 31, 2015 | -62.50% |
| December 31, 2014 | |
| September 30, 2014 | -2.69K% |
| June 30, 2014 | -153.7% |
| March 31, 2014 | 30.13% |
| December 31, 2013 | 75.24% |
| Date | Value |
|---|---|
| September 30, 2013 | -497.7% |
| June 30, 2013 | -646.1% |
| March 31, 2013 | -852.2% |
| December 31, 2012 | -1.13K% |
| September 30, 2012 | |
| June 30, 2012 | -560.8% |
| March 31, 2012 | -350.0% |
| December 31, 2011 | -11.07K% |
| September 30, 2011 | 15.55% |
| June 30, 2011 | -441.0% |
| March 31, 2011 | -17.53K% |
| December 31, 2010 | -1.29K% |
| September 30, 2010 | -3.99K% |
| June 30, 2010 | -1.89K% |
| March 31, 2010 | -2.78K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gossamer Bio Inc | 51.37% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |